1016504--10/13/2009--INTEGRATED_BIOPHARMA

related topics

{regulation, change, law}

{interest, director, officer}

{customer, product, revenue}

{provision, law, control}

{condition, economic, financial}

{stock, price, share}

{operation, natural, condition}

{financial, litigation, operation}

{debt, indebtedness, cash}

{stock, price, operating}

{product, liability, claim}

{personnel, key, retain}

Please carefully consider the following risk factors which could materially adversely affect our business, financial condition, operating results and cash flows. The risk factors described below are not the only ones we face. Risks and uncertainties not known to us currently, or that we currently deem immaterial, also may materially adversely affect our business, financial condition, operating results and cash flows. with a stated principal balance of $7.8 million, upon any default notice or at maturity could adversely affect our liquidity, business Our revenue would decline significantly if we lose one or more of our most significant customers, which could have a significant adverse impact on us. Complying with new and existing government regulation, both in the U.S. and abroad, could increase our costs significantly and adversely affect our financial results. We may be exposed to legal proceedings initiated by regulators either in the United States or abroad which could increase our costs and adversely affect our reputation, revenues and operating income. We depend on our senior management, the loss of whom would have an adverse effect on us. There is no assurance that we will remain listed on an active trading market. We have entered into several transactions with entities controlled by some of our officers and directors, which could pose a conflict of interest. Our Executive Officers and Directors have majority voting power and may take actions that may not be in the best interest of other stockholders, but in their own interest. We have a staggered Board of Directors, which could impede an attempt to acquire or remove our management. Our product liability insurance may be insufficient to cover possible claims against us. We may not be able to obtain raw materials used in certain of our manufactured products. Current economic conditions may cause a decline in business and consumer spending which could adversely affect our business and financial performance. We incur significant accounting and other control costs that impact our financial condition.

Full 10-K form ▸

1016504--10/13/2009--INTEGRATED_BIOPHARMA_INC